Dec. 26, 2017
by Andrii Buvailo
Interview
Without a doubt, the area of artificial intelligence (AI) has been a sensation lately -- judging by the amount of …
Nov. 14, 2017
by Andrii Buvailo
Undefined
In this interview, Dr. Jackie Hunter, CEO at BenevolentAI, provides insights into how the company’s AI-driven platform helps scientists create …
Sept. 24, 2017
by Andrii Buvailo
Biopharma insight
Boston-based LifeMine Therapeutics, a fresh new drug discovery startup, just announced a $55 million Series A financing from a number …
Aug. 21, 2017
by BiopharmaTrend
Undefined
This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from …
Aug. 18, 2017
by BiopharmaTrend
Undefined
IBM developed machine learning models to analyze correlations between diseases and side effects commonly caused by the medications used to …
June 17, 2017
by BiopharmaTrend
Biopharma insight
A multi-year research agreement has just been announced between Takeda Pharmaceuticals (TSE: 4502) and an Artificial Intelligence (AI)-driven computational drug …
April 2, 2017
by Andrii Buvailo
Biopharma insight
Pharmaceutical industry is rapidly evolving, influenced by emerging novel technologies and recent advances in Life Sciences and Big Data analysis, …
Dec. 3, 2016
by Andrii Buvailo
Biopharma insight
An IBM’s executive Deborah DiSanzo just announced a collaboration with a pharmaceutical giant Pfizer to speed up anticancer drug discovery. This is …
Aug. 18, 2016
by Andrii Buvailo
Biopharma insight
In 1997 a remarkable event caught everybody’s attention - the then champion of the world Garry Kasparov lost a tournament to …